Catheter Precision, Inc.
$0.97
▼
-1.06%
2026-04-21 10:11:01
www.catheterprecision.com
ASE: VTAK
Explore Catheter Precision, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$2.63 M
Current Price
$0.97
52W High / Low
$15.68 / $0.79
Stock P/E
—
Book Value
$2.62
Dividend Yield
—
ROCE
-43.77%
ROE
-1.92%
Face Value
—
EPS
$-15.9
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
—
Beta
0.26
Debt / Equity
57.83
Current Ratio
0.1
Quick Ratio
0.08
Forward P/E
-0.32
Price / Sales
3.91
Enterprise Value
$6.56 M
EV / EBITDA
-0.65
EV / Revenue
8.01
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Pulsenmore Ltd. | $3.33 | — | $72.38 M | — | -33.09% | -17.62% | $1,468 / $1,000 | — |
| 2. | CapsoVision, Inc. | $6.01 | — | $299.53 M | — | -185.75% | -1.85% | $15.37 / $3.43 | $0.28 |
| 3. | TriSalus Life Sciences, Inc. | $4.6 | — | $285.58 M | — | -113.07% | 131.29% | $7.95 / $3.42 | $-0.68 |
| 4. | Tandem Diabetes Care, Inc. | $21.24 | — | $1.47 B | — | -26.21% | -97.89% | $29.65 / $9.98 | $2.27 |
| 5. | Sera Prognostics, Inc. | $2.29 | — | $90.03 M | — | -46.95% | -51.83% | $4.09 / $1.37 | $1.94 |
| 6. | Boston Scientific Corporation | $65.03 | 33.52 | $96.13 B | 0% | 10.39% | 12.45% | $109.5 / $60.59 | $16.34 |
| 7. | enVVeno Medical Corporation | $12.08 | — | $7.92 M | — | -76.16% | -56.21% | $196.7 / $8.67 | $41.36 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0.24 M | 0.23 M | 0.21 M | 0.14 M | 0.15 M | — |
| Operating Profit | -2.87 M | -3.02 M | -2.84 M | -3.46 M | -3.05 M | — |
| Net Profit | -5.34 M | -2.34 M | -5.46 M | -4.04 M | -5.63 M | — |
| EPS in Rs | -1.98 | -0.87 | -2.03 | -1.5 | -2.09 | -38.17 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0.82 M | 0.42 M | 0.44 M | 0.01 M |
| Operating Profit | -12.18 M | -11.24 M | -17.18 M | -22.79 M |
| Net Profit | -17.18 M | -16.64 M | -70.57 M | -26.86 M |
| EPS in Rs | -6.38 | -6.18 | -26.21 | -9.98 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 15.86 M | 27.77 M | 30.74 M | 16.84 M |
| Total Liabilities | 9.21 M | 16.01 M | 9.54 M | 7.58 M |
| Equity | 7.05 M | 11.76 M | 21.19 M | 9.26 M |
| Current Assets | 0.39 M | 3.29 M | 4.16 M | 16.84 M |
| Current Liabilities | 3.91 M | 2.23 M | 2.47 M | 7.58 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -8.3 M | -9.27 M | -20.62 M | -22.57 M |
| Investing CF | 0.17 M | -0.07 M | -0.06 M | 0.02 M |
| Financing CF | 5.34 M | 8.65 M | 8.39 M | 23.36 M |
| Free CF | -8.43 M | -9.34 M | -20.7 M | -22.59 M |
| Capex | -0.13 M | -0.07 M | -0.08 M | -0.02 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -4.98% | 3057.14% | — | — |
| Earnings Growth % | 76.42% | -162.69% | — | — |
| Profit Margin % | -3962.62% | -15966.52% | -191892.86% | — |
| Operating Margin % | -2676.9% | -3888.01% | -162778.57% | — |
| Gross Margin % | 90% | 93.21% | -1050% | — |
| EBITDA Margin % | -2690.95% | -15497.06% | -159771.43% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-08-15 | 1:0.0526316 |
| 2024-07-15 | 1:0.1 |
| 2022-10-03 | 1:0.02 |